Former President and Chief Executive Officer · Arbutus Biopharma Corp (ABUS)

Mark Murray

A named executive officer of Arbutus Biopharma in every fiscal year CompBrief holds from FY2017 to FY2019. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2019

$3,780,430

Salary $273,491Stock awards $0

FY2018: $2,527,885

1st of 4 named executive officers at Arbutus Biopharma by FY2019 total.

4 named officers on file for Arbutus Biopharma, FY2019

Mark Murray’s pay file — $29

  • 3 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Arbutus Biopharma’s whole pay program stands against its peers

  • Arbutus Biopharma’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ABUS→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 24, 2020 (DEF 14A).

Free

Get Mark Murray’s full pay file as a PDF — free

More than this page: up to 10 years of Mark’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Mark Murray compensation by year

Arbutus Biopharma Summary Compensation Table · all 3 fiscal years held
In US dollars, as Arbutus Biopharma reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2017FY2018FY2019
Salary$540,000$556,000$273,491
Bonus$0$0$0
Stock awards$0$0$0
Option awards$1,003,500$1,610,020$1,193,684
Non-equity incentive$324,000$306,000$0
Pension and deferred compensation$0$0$0
All other$47,794$55,865$2,313,255
Total$1,915,294$2,527,885$3,780,430

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Arbutus Biopharma Corp DEF 14A filed April 24, 2020, accession 0001047469-20-002560, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Arbutus Biopharma Corp filed document, accession 0001047469-20-002560. Every figure is read from that document and cited to the page and table it appears in. Filed April 24, 2020.

$1.9M
$2.5M
$3.8M
FY17
FY18
FY19
SalaryNon-equity incentiveOption awardsAll other

Equity holdings

unvested awards at FY2019 year-end
TypeUnvested unitsValue at year-endExercise price
Option150,000—$3.15
Option357,500—$4.57
Option418,187—$5.20

Per the Outstanding Equity Awards at Fiscal Year-End table in Arbutus Biopharma Corp's FY2019 proxy; value at the fiscal year-end close, as the company printed it.

Arbutus Biopharma’s named executive officers, FY2019

as the company reported each
Named executive officerRoleFY2019 total
Mark Murray · this pageFormer President and Chief Executive Officer$3,780,430
William CollierPresident and Chief Executive Officer$2,334,185
Michael SofiaChief Scientific Officer$1,051,388
David HastingsChief Financial Officer$1,010,250

The full Arbutus Biopharma compensation record

free company brief

This page is one person within Arbutus Biopharma's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Arbutus Biopharma's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Mark Murray's compensation dossier · One-time report. No refunds.